Nav: Home

Healthy food prescriptions could save lives and money

March 19, 2019

Healthy food prescriptions through Medicare and Medicaid could generate substantial health gains and be highly cost-effective, according to a study published March 19 in the open-access journal PLOS Medicine by Yujin Lee and Dariush Mozaffarian of the Friedman School of Nutrition Science and Policy at Tufts University, Massachusetts, United States and colleagues. As noted by the authors, the findings support the implementation and evaluation of such programs within private and public healthcare systems.

In nearly all nations, healthcare spending continues to increase dramatically, with diet-related diseases being a major driver. Economic incentives through health insurance may promote healthier behaviors, but little is known about the health and economic impacts of incentivizing diet, a leading risk factor for diabetes and cardiovascular disease, through Medicare and Medicaid. Fruit, vegetable and other produce prescriptions have just been funded in the US through the Farm Bill with pilot programs. However, the health impacts, costs, and cost-effectiveness of the programs have not been evaluated at scale.

As a part of the Food-PRICE (Policy Review and Intervention Cost-Effectiveness) Project, Lee and colleagues estimated the health and economic impacts of healthy food prescriptions for adults in Medicare and Medicaid, the two largest US federal health insurance programs, which together cover 1 in 3 Americans.

Using nationally representative data and a validated model, they evaluated two scenarios: (1) 30% incentives for the cost of purchases of fruits and vegetables (F&V incentive), and (2) 30% incentives for the cost of purchases of several healthful foods, including fruits, vegetables, whole grains, nuts/seeds, seafood, and plant oils (healthy food incentive).

Over a lifetime, the study suggests that the F&V incentive could prevent 1.93 million cardiovascular disease events, including 0.35 million cardiovascular deaths, and save about $40 billion in healthcare costs. The healthy food incentive could prevent 3.28 million cardiovascular disease events, including 0.62 million cardiovascular deaths and 0.12 million diabetes cases, and save $100 billion in healthcare costs.

Both programs would be highly cost-effective from healthcare and societal perspectives, with lifetime incremental cost-effectiveness ratios ranging from more than $9,000 to approximately $18,000 per quality-adjusted life year. Taken together, the findings suggest that implementing healthy food prescriptions within large government healthcare programs to promote healthier eating could generate substantial health gains and be highly cost-effective.
-end-
Research Article

Funding:

This research was supported by the National Institutes of Health, National Heart, Lung, and Blood Institute (R01 HL130735, PI RM; R01 HL115189, PI DM), https://www.nhlbi.nih.gov/. In addition, JL was supported by a postdoctoral fellowship award (17POST33670808) from the American Heart Association, http://www.heart.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests:

I have read the journal's policy and the authors of this manuscript have the following competing interests: RM reports research funding from NIH, Bill & Melinda Gates Foundation, and Unilever and personal fees from the World Bank and Bunge. DM reports research funding from the National Institutes of Health and the Gates Foundation; personal fees from GOED, Nutrition Impact, Pollock Communications, Bunge, Indigo Agriculture, Amarin, Acasti Pharma, Cleveland Clinic Foundation, America's Test Kitchen, and Danone; scientific advisory board, Elysium Health (with stock options), Omada Health, and DayTwo; and chapter royalties from UpToDate, all outside the submitted work. TAG has also received research funds and/or consulting fees from Astra Zeneca, Novartis, United Health Group, Teva Pharmacueticals, and Takeda in the past five years, all of which were outside the submitted work.

Citation:

Lee Y, Mozaffarian D, Sy S, Huang Y, Liu J, Wilde PE, et al. (2019) Cost-effectiveness of financial incentives for improving diet and health through Medicare and Medicaid: A microsimulation study. PLoS Med 16(3): e1002761. https://doi.org/10.1371/journal.pmed.1002761

Author Affiliations:

Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts, United States of America

Brigham and Women's Hospital, Boston, Massachusetts, United States of America

Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America

In your coverage please use this URL to provide access to the freely available paper: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002761

PLOS

Related Cardiovascular Disease Articles:

Is educational attainment associated with lifetime risk of cardiovascular disease?
Men and women with the lowest education level had higher lifetime risks of cardiovascular disease than those with the highest education level, according to a new study published by JAMA Internal Medicine.
Food policies could lower US cardiovascular disease rates
New research conducted by the University of Liverpool and partners shows that food policies, such as fruit and vegetable subsidies, taxes on sugar sweetened drinks, and mass media campaigns to change dietary habits, could avert hundreds of thousands of deaths from cardiovascular disease (CVD) in the United States.
Cardiovascular disease causes one-third of deaths worldwide
Cardiovascular diseases (CVD), including heart diseases and stroke, account for one-third of deaths throughout the world, according to a new scientific study that examined every country over the past 25 years.
Kidney disease is a major cause of cardiovascular deaths
In 2013, reduced kidney function was associated with 4 percent of deaths worldwide, or 2.2 million deaths.
Cardiovascular disease costs will exceed $1 trillion by 2035
A new study projects that by 2035, cardiovascular disease, the most costly and prevalent killer, if left unchecked, will place a crushing economic and health burden on the nation's financial and health care systems.
Prescribing drugs for cardiovascular disease prevention in the UK
Drugs such as statins that have the potential to prevent strokes and other types of cardiovascular disease have not been prescribed to a large proportion of people at risk in the UK, according to a research article by Grace Turner of the University of Birmingham, Birmingham, UK and colleagues published in PLOS Medicine.
Fatty liver disease contributes to cardiovascular disease and vice versa
For the first time, researchers have shown that a bi-directional relationship exists between fatty liver disease and cardiovascular disease.
More dietary calcium may lower risk of cardiovascular disease
In older people, higher dietary calcium intake may lower the risk of cardiovascular disease, but not of stroke and fracture, new research from South Korea suggests.
Renal hemodynamics and cardiovascular function in health and disease
The SRC will focus on unpublished work that is state-of-the-art in study of cardiovascular and renal disease and hypertension.
Cardiovascular disease in adult survivors of childhood cancer
For adult survivors of childhood cancer, cardiovascular disease presents at an earlier age, is associated with substantial morbidity, and is often asymptomatic.

Related Cardiovascular Disease Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...